• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔法至奥密克戎:主要 SARS-CoV-2 变异株的疾病严重程度和临床结局。

Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants.

机构信息

Center for Pediatric Infectious Disease, Cleveland Clinic Childrens, Cleveland, Ohio, USA.

Department of Computer and Data Sciences, Case Western Reserve University, Cleveland, Ohio, USA.

出版信息

J Infect Dis. 2023 Feb 1;227(3):344-352. doi: 10.1093/infdis/jiac411.

DOI:10.1093/infdis/jiac411
PMID:36214810
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9619650/
Abstract

BACKGROUND

Four severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants predominated in the United States since 2021. Understanding disease severity related to different SARS-CoV-2 variants remains limited.

METHOD

Viral genome analysis was performed on SARS-CoV-2 clinical isolates circulating March 2021 through March 2022 in Cleveland, Ohio. Major variants were correlated with disease severity and patient outcomes.

RESULTS

In total 2779 patients identified with either Alpha (n 1153), Gamma (n 122), Delta (n 808), or Omicron variants (n 696) were selected for analysis. No difference in frequency of hospitalization, intensive care unit (ICU) admission, and death were found among Alpha, Gamma, and Delta variants. However, patients with Omicron infection were significantly less likely to be admitted to the hospital, require oxygen, or admission to the ICU (2 12.8, P .001; 2 21.6, P .002; 2 9.6, P .01, respectively). In patients whose vaccination status was known, a substantial number had breakthrough infections with Delta or Omicron variants (218/808 [26.9] and 513/696 [73.7], respectively). In breakthrough infections, hospitalization rate was similar regardless of variant by multivariate analysis. No difference in disease severity was identified between Omicron subvariants BA.1 and BA.2.

CONCLUSIONS

Disease severity associated with Alpha, Gamma, and Delta variants is comparable while Omicron infections are significantly less severe. Breakthrough disease is significantly more common in patients with Omicron infection.

摘要

背景

自 2021 年以来,四种严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)变体在美国占主导地位。对不同 SARS-CoV-2 变体与疾病严重程度的关系了解有限。

方法

对 2021 年 3 月至 2022 年 3 月在俄亥俄州克利夫兰循环的 SARS-CoV-2 临床分离株进行病毒基因组分析。主要变体与疾病严重程度和患者结局相关。

结果

共选择了 2779 名患有 Alpha(n=1153)、Gamma(n=122)、Delta(n=808)或 Omicron 变体(n=696)的患者进行分析。Alpha、Gamma 和 Delta 变体在住院、重症监护病房(ICU)入院和死亡的频率上没有差异。然而,感染 Omicron 的患者住院、需要吸氧或 ICU 入院的可能性显著降低(2 12.8,P.001;2 21.6,P.002;2 9.6,P.01)。在已知疫苗接种状态的患者中,大量患者出现了 Delta 或 Omicron 变体的突破性感染(218/808[26.9]和 513/696[73.7])。在突破性感染中,多变量分析显示,无论变体如何,住院率相似。在 Omicron 亚变体 BA.1 和 BA.2 中,未发现疾病严重程度存在差异。

结论

与 Alpha、Gamma 和 Delta 变体相关的疾病严重程度相当,而 Omicron 感染明显较轻。Omicron 感染患者的突破性疾病更为常见。

相似文献

1
Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants.阿尔法至奥密克戎:主要 SARS-CoV-2 变异株的疾病严重程度和临床结局。
J Infect Dis. 2023 Feb 1;227(3):344-352. doi: 10.1093/infdis/jiac411.
2
Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey.新泽西州一家大型医疗机构中接种和未接种人群中 SARS-CoV-2 感染的分子和临床流行病学研究。
Viruses. 2023 Aug 5;15(8):1699. doi: 10.3390/v15081699.
3
Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes.在意大利一家参考医院因 COVID-19 住院的患者中,德尔塔和奥密克戎共同流行期间关注的 SARS-CoV-2 变异株的演变:对临床结局的影响。
J Med Virol. 2023 Jun;95(6):e28831. doi: 10.1002/jmv.28831.
4
Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants.奥密克戎亚变体的中和敏感性、融合性和感染性。
Genome Med. 2022 Dec 29;14(1):146. doi: 10.1186/s13073-022-01151-6.
5
Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.新英格兰地区估计 SARS-CoV-2 奥密克戎 BA.2 亚变种的严重程度。
JAMA Netw Open. 2022 Oct 3;5(10):e2238354. doi: 10.1001/jamanetworkopen.2022.38354.
6
Analysis of SARS-CoV-2 genomic surveillance data during the Delta and Omicron waves at a Saudi tertiary referral hospital.沙特三级转诊医院在德尔塔和奥密克戎流行期间对 SARS-CoV-2 基因组监测数据的分析。
J Infect Public Health. 2023 Feb;16(2):171-181. doi: 10.1016/j.jiph.2022.12.007. Epub 2022 Dec 14.
7
Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.SARS-CoV-2 的 Alpha、Delta 和奥密克戎变异株的替代动力学和发病机制。
Epidemiol Infect. 2022 Dec 20;151:e32. doi: 10.1017/S0950268822001935.
8
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间,加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局,期间 B.1.617.2(德尔塔)和 B.1.1.529(奥密克戎)变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
9
Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants.同时传播的严重急性呼吸综合征冠状病毒2变种的住院风险和重症风险比较
J Infect Dis. 2023 Feb 1;227(3):332-338. doi: 10.1093/infdis/jiac385.
10
Shift in SARS-CoV-2 variants of concern from Delta to Omicron was associated with reduced hospitalizations, increased risk of breakthrough infections but lesser disease severity.从德尔塔变异株到奥密克戎变异株的转变与住院人数减少、突破性感染风险增加有关,但疾病严重程度较低。
J Infect Public Health. 2024 Jun;17(6):1100-1107. doi: 10.1016/j.jiph.2024.04.025. Epub 2024 May 3.

引用本文的文献

1
Differences in the Clinical Course of COVID-19 in Patients Hospitalized in the 2023/2024 and 2024/2025 Seasons.2023/2024年和2024/2025年住院的COVID-19患者临床病程差异。
J Clin Med. 2025 Aug 25;14(17):5992. doi: 10.3390/jcm14175992.
2
Breathless Aftermath: Post-COVID-19 Pulmonary Fibrosis.气喘吁吁的后果:新冠后肺纤维化
Viruses. 2025 Aug 9;17(8):1098. doi: 10.3390/v17081098.
3
COVID-19-Related Healthcare Resource Utilisation and Costs in Paediatric Patients in Germany: A Population-Based Study.德国儿科患者中与新冠病毒病相关的医疗资源利用及成本:一项基于人群的研究
Adv Ther. 2025 Aug 11. doi: 10.1007/s12325-025-03313-5.
4
Misattribution Bias of COVID-19 Hospitalizations in Alberta Using an Admission Algorithm.使用入院算法对阿尔伯塔省新冠肺炎住院病例的错误归因偏差
J Assoc Med Microbiol Infect Dis Can. 2024 Dec 19;9(4):274-283. doi: 10.3138/jammi-2024-0011. eCollection 2024 Dec.
5
Understanding the long-term interplay of SARS-CoV-2 immune and inflammatory responses with proteases in COVID-19 recovery: a longitudinal study.了解SARS-CoV-2免疫和炎症反应与蛋白酶在新冠病毒感染康复过程中的长期相互作用:一项纵向研究
Front Immunol. 2025 Jun 10;16:1517933. doi: 10.3389/fimmu.2025.1517933. eCollection 2025.
6
Predicting the evolutionary and epidemiological dynamics of SARS-CoV-2 in South Africa.预测南非新冠病毒的进化和流行病学动态。
Virulence. 2025 Dec;16(1):2520335. doi: 10.1080/21505594.2025.2520335. Epub 2025 Aug 3.
7
The presence of neutralizing antibodies against omicron subvariants among a vaccinated cohort at one year after the first dose of vaccination in Malaysia.在马来西亚,首剂疫苗接种一年后,接种疫苗人群中针对奥密克戎亚变体的中和抗体的存在情况。
Sci Rep. 2025 Jun 1;15(1):19191. doi: 10.1038/s41598-025-03798-8.
8
Trajectories of Health-Related Quality of Life 2 Years After Mild/Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Pre-Omicron Era.在奥密克戎时代之前,轻度/中度严重急性呼吸综合征冠状病毒2感染后2年的健康相关生活质量轨迹。
Open Forum Infect Dis. 2025 Mar 27;12(5):ofaf142. doi: 10.1093/ofid/ofaf142. eCollection 2025 May.
9
Comparison of the pathogenicity of multiple SARS-CoV-2 variants in mouse models.多种新冠病毒变异株在小鼠模型中的致病性比较。
Animal Model Exp Med. 2025 Jul;8(7):1302-1312. doi: 10.1002/ame2.70029. Epub 2025 May 20.
10
In-hospital mortality among children and adults hospitalized with COVID-19 in Africa across pre-delta, delta, and omicron SARS-CoV-2 waves.在非洲,儿童和成人因感染新冠病毒住院,在德尔塔毒株出现之前、德尔塔毒株时期以及奥密克戎毒株时期的住院死亡率。
Int J Infect Dis. 2025 Aug;157:107924. doi: 10.1016/j.ijid.2025.107924. Epub 2025 May 8.